ERα inhibits the progression of hepatocellular carcinoma by regulating the circRNA/miRNA/SMADs network

ERα can function as aTF, modulating the expression of various circRNAs with differential expression in HCC. Through this regulation, it modulates the circRNA/miRNA/SMADs network, thereby inhibiting the progression of HCC.

Authors

Institutions

Publication Details

Journal
Advances in Clinical and Experimental Medicine
Published
2026-01-05
DOI
https://doi.org/10.17219/acem/203285
Primary Topic
Circular RNAs in diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ERα inhibits the progression of hepatocellular carcinoma by regulating the circRNA/miRNA/SMADs network

Zujian Wu, Changfeng Liu, zhi chen, Bing Zhang
Advances in Clinical and Experimental Medicine
Circular RNAs in diseases
article

ERα inhibits the progression of hepatocellular carcinoma by regulating the circRNA/miRNA/SMADs network

Zujian Wu, Changfeng Liu, zhi chen, Bing Zhang
article en

Abstract

ERα can function as aTF, modulating the expression of various circRNAs with differential expression in HCC. Through this regulation, it modulates the circRNA/miRNA/SMADs network, thereby inhibiting the progression of HCC.

Advances in Clinical and Experimental MedicineVol. 35(1)
Tongde Hospital of Zhejiang Province (CN)
Chinese Medicine Research Program of Zhejiang Province
Good health and well-being
Openalex Percentile: Top 97%
Circular RNAs in diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ERα inhibits the progression of hepatocellular carcinoma by regulating the circRNA/miRNA/SMADs network — Zujian Wu, Changfeng Liu, et al. · Advances in Clinical and Experimental Medicine (2026) | TGRS Research Map | TGRS